Laekna, Inc. — Proxy Solicitation & Information Statement 2026

May 14, 2026

Lekna

Laekna, Inc.

來凱醫藥有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2105)

PROXY FORM FOR THE ANNUAL GENERAL MEETING

I/We, being the registered holder(s) in the capital of the Company, hereby appoint the Chairman of the meeting $^{(None 2 and 3)}$ or the proxy as specified below to act as my/our proxy to attend and vote for me/us and on my/our behalf at the annual general meeting (the "AGM") of the Company to be held at 9:00 a.m. on Friday, 5 June 2026 at 5F, 987 Callun Road, Pudong, Shanghai, China, at any adjournment thereof and to exercise all rights conferred on proxies under law, regulation and the Articles of Association of the Company. Terms used in this proxy form, shall have the same meanings as defined in the circular of the Company dated 14 May 2026 unless the context otherwise requires.

I/We wish my/our proxy to vote as indicated below in respect of the resolution/resolutions to be proposed at the AGM (and at any adjournment thereof).

Please indicate how you wish your vote(s) to be cast by putting a “√” in the appropriate box next to the following resolution. $^{(None 4)}$

Registered Holder(s) (Complete in ENGLISH BLOCK CAPITALS. The names of all joint holders should be stated.)
Registered Name $^{(None 1)}$
Registered Address $^{(None 5)}$
Registered Shareholding	Certificate No.	Date (DD-MM-YYYY)	Signature $^{(None 6)}$
Proxy (Complete in ENGLISH BLOCK CAPITALS.)
Full Name
Full Address
No. of Shares $^{(None 7)}$		Email Address
ORDINARY RESOLUTIONS		FOR	AGAINST
---	---	---	---
1.	To receive and adopt the audited consolidated financial statements and the reports of the directors of the Company (the "Directors") and auditor for the year ended 31 December 2025.
2.	(i) To re-elect Dr. LU Chris Xiangyang as an executive Director.
	(ii) To re-elect Ms. XIE Ling as an executive Director.
	(iii) To re-elect Dr. LI Min as an independent non-executive Director.
	(iv) To authorize the board of Directors to fix the remuneration of the Directors.
3.	To re-appoint KPMG as auditor and to authorize the board of Directors to fix its remuneration.
4.	To grant a general mandate to the Directors to allot, issue and deal with additional shares of the Company (including a sale or transfer of treasury shares out of treasury) not exceeding 20% of the number of shares of the Company in issue (excluding treasury shares, if any).
5.	To grant a general mandate to the Directors to repurchase shares of the Company not exceeding 10% of the number of shares of the Company in issue (excluding treasury shares, if any).
6.	To extend the authority given to the Directors pursuant to ordinary resolution no. 4 to issue shares by adding to the issued share capital of the Company repurchased under ordinary resolution no. 5.
7.	To consider and approve the grant of 2,550,000 RSUs under the 2024 Share Award Scheme to Dr. LU Chris Xiangyang.
8.	To consider and approve the grant of 2,550,000 RSUs under the 2024 Share Award Scheme to Ms. XIE Ling.
9.	To consider and approve the grant of 2,550,000 RSUs under the 2024 Share Award Scheme to Dr. GU Xiang-Ju Justin.

• The full text of the Resolutions is set out in the Notice of the Annual General Meeting which is included in the Circular published on 14 May 2026.

Notes:

1. Please insert full name(s) in BLOCK CAPITALS as shown in the register of members of the Company.
2. If you are a shareholder who is entitled to attend and vote at the AGM, you are entitled to appoint one or more proxies to attend instead of you and to vote on your behalf provided that each proxy is appointed to represent the respective number of shares held by you as specified in the relevant proxy form. A proxy need not be a shareholder of the Company, but must attend the AGM in person in order to represent you.
3. If a proxy other than the Chairman of the meeting is preferred, cross out the words "the Chairman of the meeting" and insert the full name(s) and address(es) of the proxy (or proxies) desired in the space provided. If no name is inserted, the Chairman of the meeting will act as your proxy. Any changes should be initiated.
4. If you return this proxy form without indicating as to how your proxy is to vote on any particular matter, the person appointed as your proxy will exercise his/her discretion as to whether he/she votes and, if so, how and, unless instructed otherwise, he/she may also vote or abstain from voting as he/she thinks fit on any other business (including amendments or resolutions) which may properly come before the AGM.
5. Please insert full address(es) in BLOCK CAPITALS as shown in the register of members of the Company.
6. This proxy form must be signed and dated by the shareholder or his/her attorney duly authorized in writing. If the shareholder is a company, it should execute this proxy form under its common seal or by the signature(s) of (a) person(s) authorized to sign on its behalf. In case of joint shareholding, any one shareholder may sign this proxy form. The vote of the senior joint shareholder who tenders a vote, whether in person or by proxy, shall be accepted to the exclusion of the vote(s) of the other joint shareholder(s) and for this purpose seniority will be determined by the order in which the names stand in the register of members of the Company in respect of the joint shareholding.
7. Please insert the number of shares registered in your name(s); if no number is inserted, this proxy form will be deemed to relate to all shares in the capital of the Company registered in your name(s).
8. In order to be valid, this proxy form must be completed and deposited at the Company's Share Registrar at 17M Floor, Hopowell Centre, 103 Queen's Road East, Wan Chai, Hong Kong, at least 48 hours before the AGM (or the adjournment thereof). If this proxy form is signed under a power of attorney, the power of attorney or other authority relied on to sign it (or a copy which has been certified by a notary public) must be deposited at the Company's share registrar with this proxy form.
9. Completion and delivery of this proxy form will not preclude you from attending and voting in person at the AGM (and at any adjournment thereof) if you so wish.

PERSONAL INFORMATION COLLECTION STATEMENT

"Personal Data" in this statement has the same meaning as "personal data" in the Personal Data (Privacy) Ordinance, Cap 686 (PDPO), which will include your and your appointed proxy's name and mailing address and any another personal data required to be provided. By providing your appointed proxy's Personal Data, you hereby confirm that you have obtained the consent of your appointed proxy to provide their Personal Data to the Company and its Registrars. The Personal Data provided in this form may be used in connection with processing your appointment of proxy at the Company's AGM and instructions. Your supply of the Personal Data to the Company and/or its Registrars is on a voluntary basis. However, we may not be able to effect the appointment of your proxy and instructions unless you provide us with the Personal Data. The Personal Data will be transferred to the Registrars' agents, contractors or third-party service providers who/which offer administrative, telecommunications, computer, payment or other data processing services to the Registrars in connection with the operation of their business for the above purposes. The Company and its Registrars may also transfer your Personal Data if it is required to do so by law or in response to requests from law enforcement agencies or regulatory authorities. The Personal Data collected in this proxy form will be retained for such period as may be necessary for any of the above purposes and its directly related purposes such as for the Company's and its Registrar's record, verification and notification purposes. You and your appointed proxy have the right to request access to, correction and/or reware of the respective Personal Data in accordance with, where applicable, the provisions of the PDPO, and any other data protection law as applicable. Any such request for access to, correction and/or reware of the Personal Data, as well as withdrawal of consent, where applicable, should be made in writing by either one of the following means:

By mail to: Hong Kong Privacy Officer
Computershare Hong Kong Services Services Limited
17M Floor, Hopowell Centre, 103 Queen's Road East, Wanchai, Hong Kong

By email to: PrivacyOfficer@computershare.com.hk.